Low-molecular-weight proteins as prognostic markers in idiopathic membranous nephropathy

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 12, 2011, Pages 2846-2853

  van den Brand, Jan A J G ^a   Hofstra, Julia M ^a   Wetzels, Jack F M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA 1 MICROGLOBULIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA 2 MICROGLOBULIN; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN G;

ACCURACY; ADULT; AGED; ALBUMIN BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; FEMALE; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MOLECULAR WEIGHT; PREDICTIVE VALUE; PROGNOSIS; PROTEIN URINE LEVEL; PROTEINURIA; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SURVIVAL;

ADULT; ALPHA-GLOBULINS; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; CREATININE; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; MALE; MIDDLE AGED; MOLECULAR WEIGHT; PROGNOSIS; PROTEINURIA;

EID: 83155182239     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04020411     Document Type: Article

References (24)

1. Cattran DC. Membranous nephropathy. In: Primer on Kidney Diseases, 5th ed., edited by Greenberg A, Cheung AK, Coffman TM, Falk RJ, Jennette JC, Philadelphia, Saunders Elsevier, 2009, pp 170-178
2. Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC: Idiopathic membranous nephropathy: Definition and relevance of a partial remission. Kidney Int 66: 1199-1205, 2004
3. Polanco N, Gutierrez E, Covarsi A, Ariza F, Carreno A, Vigil A, Baltar J, Fernández-Fresnedo G, Martín C, Pons S, Lorenzo D, Bernis C, Arrizabalaga P, Fernández-Juárez G, Barrio V, Sierra M, Castellanos I, Espinosa M, Rivera F, Oliet A, Fernández-Vega F, Praga M: Grupo de Estudio de las Enfermedades Glomerulares de la Sociedad Española de Nefrología.: Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy. J Am Soc Nephrol 21: 697-704, 2010
4. Cattran DC, Pei Y, Greenwood CM, Ponticelli C, Passerini P, Honkanen E: Validation of a predictive model of idiopathic membranous nephropathy: Its clinical and research implications. Kidney Int 51: 901-907, 1997
5. du Buf-Vereijken PW, Branten AJ, Wetzels JF: Idiopathic membranous nephropathy: Outline and rationale of a treatment strategy. Am J Kidney Dis 46: 1012-1029, 2005
6. Ponticelli C, Zucchelli P, Passerini P, Cesana B, Locatelli F, Pasquali S, Sasdelli M, Redaelli B, Grassi C, Pozzi C, Bizarri D, Banfi G: A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int 48: 1600-1604, 1995
7. Jha V, Ganguli A, Saha TK, Kohli HS, Sud K, Gupta KL, Joshi K, Sakhuja V: A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy. J Am Soc Nephrol 18: 1899-1904, 2007
8. Hofstra JM, Wetzels JF: Alkylating agents in membranous nephropathy: Efficacy proven beyond doubt. Nephrol Dial Transplant 25: 1760-1766, 2010
9. Reichert LJ, Koene RA, Wetzels JF: Prognostic factors in idiopathic membranous nephropathy. Am J Kidney Dis 31: 1-11, 1998
10. Pei Y, Cattran D, Greenwood C: Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis. Kidney Int 42: 960-966, 1992
11. Ponticelli C, Passerini P, Altieri P, Locatelli F, Pappalettera M: Remissions and relapses in idiopathic membranous nephropathy. Nephrol Dial Transplant 7 Suppl 1: 85-90, 1992
12. Ponticelli C, Passerini P: Can prognostic factors assist therapeutic decisions in idiopathic membranous nephropathy? J Nephrol 23: 156-163, 2010
13. Honkanen E, Teppo AM, Meri S, Lehto T, Gronhagen-Riska C: Urinary excretion of cytokines and complement SC5b-9 in idiopathic membranous glomerulonephritis. Nephrol Dial Transplant 9: 1553-1559, 1994
14. Kon SP, Coupes B, Short CD, Solomon LR, Raftery MJ, Mallick NP, Brenchley PE: Urinary C5b-9 excretion and clinical course in idiopathic human membranous nephropathy. Kidney Int 48: 1953-1958, 1995
15. Reichert LJ, Koene RA, Wetzels JF: Urinary excretion of beta 2-microglobulin predicts renal outcome in patients with idiopathic membranous nephropathy. J Am Soc Nephrol 6: 1666-1669, 1995
16. Honkanen E, Teppo AM, Tornroth T, Groop PH, Gronhagen-Riska C: Urinary transforming growth factor-beta 1 in membranous glomerulonephritis. Nephrol Dial Transplant 12: 2562-2568, 1997
17. Reichert LJ, Koene RA, Wetzels JF: Urinary IgG excretion as a prognostic factor in idiopathic membranous nephropathy. Clin Nephrol 48: 79-84, 1997
18. Bazzi C, Petrini C, Rizza V, Arrigo G, Napodano P, Paparella M, Di Amico G: Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Nephrol Dial Transplant 17: 1890-1896, 2002
19. Hofstra JM, Deegens JK, Willems HL, Wetzels JF: Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy. Nephrol Dial Transplant 23: 2546-2551, 2008
20. Branten AJ, du Buf-Vereijken PW, Klasen IS, Bosch FH, Feith GW, Hollander DA, Wetzels JF: Urinary excretion of beta2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: A validation study. J Am Soc Nephrol 16: 169-174, 2005
21. Hofstra JM, Branten AJ, Wirtz JJ, Noordzij TC, du Buf-Vereijken PW, Wetzels JF: Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: A randomized controlled trial. Nephrol Dial Transplant 25: 129-136, 2010
22. Jacobs EM, Vervoort G, Branten AJ, Klasen I, Smits P, Wetzels JF: Atrial natriuretic peptide increases albuminuria in type I diabetic patients: Evidence for blockade of tubular protein reabsorption. Eur J Clin Invest 29: 109-115, 1999
23. Hofstra JM, Deegens JK, Steenbergen EJ, Wetzels JF: Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy. Nephrol Dial Transplant 23: 3160-3165, 2008
24. Cattran DC: Membranous nephropathy: Quo vadis? Kidney Int 61: 349-350, 2002